Uncategorized
Silexion Therapeutics’ Preclinical Cancer Candidate Shows Tumor Reduction For Pancreatic Cancer
Silexion’s SIL204 reduced tumor growth and metastases in pancreatic cancer models, showing strong efficacy across KRAS mutation profiles in preclinical studies. read more
ChargePoint Analyst Remains Cautious About Long-Term Profitability
CHPT shares up after JPMorgan analyst remains underweight with $0.81 price forecast following Q4 results. Revenue and margins expected to improve. read more
Wall Street Awaits Trump’s Tariff Decision, Digests Mixed Economic Data: What’s Driving Markets Wednesday?
The three major indices were mostly flat in midday trading Wednesday with the S&P 500 and Nasdaq slightly under the flatline and the Dow Jones up 39 points. read more
Dine Brands Q4 Earnings: Sales Dip, EPS Miss, Negative Comps For Applebee’s, IHOP And More
Dine Brands Q4 earnings beat estimates but sales dip due to lower franchise revenues, with a modest outlook for FY25 same-restaurant sales. read more
NBA Legend Shaq Never Held Bitcoin Or XRP, But There’s One Other Trump Crypto Reserve Coin He Bought In 2021
Shaquille O’Neal, the NBA legend turned business mogul, has consistently voiced skepticism about cryptocurrency, yet evidence reveals he dipped into the market with a $20, read more
Victoria’s Secret Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Latest Ratings for VSCO Date Firm Action From To Mar 2022 Wells Fargo Maintains Overweight Jan 2022 UBS Initiates Coverage On Neutral Dec 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for VSCO View the Latest Analyst Ratings read more
Cutera (CUTR) Shares Are Down 45% Today: What’s Going On?
Cutera shares are trading lower by 48% during Wednesday’s session. The company announced a restructuring plan backed by lenders. read more